Rare diseases
Investigational molecules
Locations
Back to Austria286 clinical trials in Salzburg, Austria across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer
AustriaStudy Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma
AustriaStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
AustriaStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
AustriaStudy on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
AustriaAustriaStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
AustriaStudy of Florastamin (18F) PET/CT Imaging for Detection of Significant Prostate Cancer in Patients with Elevated PSA Levels and Unclear MRI Results
AustriaStudy on Izokibep for Patients with Non-infectious Uveitis
AustriaStudy of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
AustriaStudy of AMG 193 alone and combined with docetaxel for treatment of advanced MTAP-null solid tumors in adult patients
AustriaStudy Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement
AustriaThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on metastatic cancers and innovative treatment approaches, including trials investigating new therapies for prostate cancer, colorectal cancer, and bladder cancer.
Multiple clinical trials evaluating targeted therapies and combination treatments for various stages of cancer progression.
Investigating breakthrough treatments for multiple myeloma and acute myeloid leukemia, with emphasis on innovative therapeutic combinations and targeted approaches.
Focus on improving outcomes for patients with various blood disorders through advanced therapeutic strategies.
Research initiatives addressing cardiovascular disease, Crohn's disease, and Alzheimer's disease, exploring new treatment modalities and therapeutic approaches.
Comprehensive studies aimed at developing more effective treatments for chronic conditions affecting quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
